A 38-year-old woman from rural Maharashtra presents with a 2-week history of jaundice, pruritus, and pale stools. She reports no fever or abdominal pain. On examination, she is afebrile, with icteric sclera and hepatomegaly (liver edge 3 cm below costal margin, smooth, non-tender). Laboratory investigations show: total bilirubin 8.2 mg/dL (direct 6.8 mg/dL), AST 45 U/L, ALT 52 U/L, ALP 280 U/L, GGT 320 U/L. Abdominal ultrasound reveals dilated intrahepatic bile ducts (IHBD) and a normal common bile duct (CBD) diameter of 4 mm. What is the most likely diagnosis?

Explanation

## Clinical Presentation Analysis **Key Point:** The constellation of jaundice, pruritus, pale stools, and markedly elevated ALP/GGT with only mild transaminitis points to a **cholestatic pattern** of liver injury. ### Laboratory Pattern Recognition | Parameter | Value | Interpretation | |-----------|-------|----------------| | Direct bilirubin | 6.8 mg/dL (83% of total) | Cholestasis | | AST/ALT | 45–52 U/L | Mild elevation (cholestasis, not hepatitis) | | ALP | 280 U/L | Markedly elevated | | GGT | 320 U/L | Confirms hepatic origin of ALP | **High-Yield:** ALP > 4× upper limit of normal with transaminases < 3× ULN = **cholestatic pattern**. ### Imaging Findings **Key Point:** Dilated IHBD with **normal CBD diameter** rules out **extrahepatic obstruction** (stone, stricture, malignancy). This is the critical discriminator. - Normal CBD (4 mm) excludes choledocholithiasis and CBD obstruction - Dilated IHBD suggests intrahepatic cholestasis or primary biliary disease ### Differential Diagnosis ```mermaid flowchart TD A[Jaundice + Pruritus + Pale Stools]:::outcome --> B{Bilirubin pattern?}:::decision B -->|Direct > 50%| C[Cholestasis]:::outcome C --> D{AST/ALT elevation?}:::decision D -->|Mild <3× ULN| E[Cholestatic pattern]:::outcome E --> F{CBD dilated?}:::decision F -->|No, normal| G[Intrahepatic cholestasis]:::outcome G --> H{Female + pruritus + smooth hepatomegaly?}:::decision H -->|Yes| I[Primary Biliary Cholangitis]:::action F -->|Yes, >6 mm| J[Extrahepatic obstruction]:::urgent ``` ### Why Primary Biliary Cholangitis (PBC)? 1. **Female predominance** (90% of PBC cases are women) 2. **Cholestatic biochemistry** (ALP >> transaminases) 3. **Pruritus** — often the earliest symptom in PBC 4. **Smooth hepatomegaly** — consistent with chronic liver disease 5. **Intrahepatic bile duct dilatation** — reflects progressive cholestasis within the liver parenchyma 6. **Normal CBD** — excludes mechanical obstruction **Clinical Pearl:** PBC is an autoimmune destruction of small intrahepatic bile ducts. The normal CBD rules out secondary causes (stones, strictures, tumors). ### Confirmatory Tests (Not in Vignette but Diagnostic) - **Anti-mitochondrial antibody (AMA)** — present in >95% of PBC patients - **Anti-M2 antibody** — highly specific for PBC - **Liver biopsy** — shows destruction of interlobular bile ducts (florid duct lesion) **High-Yield:** PBC is the most common autoimmune liver disease in developed countries and increasingly recognized in India.